Genenta Science S.p.A. is involved in the biotechnology sector, focusing on the development of gene therapies for the treatment of cancer and other diseases. The company operates by leveraging its proprietary platform to create therapies that utilize genetically modified cells. Genenta serves healthcare providers and patients, primarily in the oncology field, and is engaged in research and development activities to advance its therapeutic offerings.
- Website
- www.genenta.com
- Issuer profile
- All listings